Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
UCSF Helen Diller Family Comprehensive Cancer Center.
J Natl Compr Canc Netw. 2022 Oct;20(10):1139-1167. doi: 10.6004/jnccn.2022.0051.
This selection from the NCCN Guidelines for Rectal Cancer focuses on management of malignant polyps and resectable nonmetastatic rectal cancer because important updates have been made to these guidelines. These recent updates include redrawing the algorithms for stage II and III disease to reflect new data supporting the increasingly prominent role of total neoadjuvant therapy, expanded recommendations for short-course radiation therapy techniques, and new recommendations for a "watch-and-wait" nonoperative management technique for patients with cancer that shows a complete response to neoadjuvant therapy. The complete version of the NCCN Guidelines for Rectal Cancer, available online at NCCN.org, covers additional topics including risk assessment, pathology and staging, management of metastatic disease, posttreatment surveillance, treatment of recurrent disease, and survivorship.
本 NCCN 直肠癌指南精选版重点关注恶性息肉和可切除的非转移性直肠癌的管理，因为这些指南已经进行了重要更新。这些最新更新包括重新绘制 II 期和 III 期疾病的算法，以反映支持新辅助全直肠治疗作用日益突出的新数据，扩大短程放疗技术的推荐，以及对新辅助治疗显示完全缓解的患者采用“观察等待”非手术治疗技术的新建议。可在线在 NCCN.org 获得的完整 NCCN 直肠癌指南版本涵盖了其他主题，包括风险评估、病理学和分期、转移性疾病的管理、治疗后监测、复发性疾病的治疗以及生存。
